These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 35530128)

  • 1. Free energy perturbation (FEP)-guided scaffold hopping.
    Wu D; Zheng X; Liu R; Li Z; Jiang Z; Zhou Q; Huang Y; Wu XN; Zhang C; Huang YY; Luo HB
    Acta Pharm Sin B; 2022 Mar; 12(3):1351-1362. PubMed ID: 35530128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absolute Binding Free Energy Calculation and Design of a Subnanomolar Inhibitor of Phosphodiesterase-10.
    Li Z; Huang Y; Wu Y; Chen J; Wu D; Zhan CG; Luo HB
    J Med Chem; 2019 Feb; 62(4):2099-2111. PubMed ID: 30689375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accurate Modeling of Scaffold Hopping Transformations in Drug Discovery.
    Wang L; Deng Y; Wu Y; Kim B; LeBard DN; Wandschneider D; Beachy M; Friesner RA; Abel R
    J Chem Theory Comput; 2017 Jan; 13(1):42-54. PubMed ID: 27933808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation on the binding mechanism of loratinib with the c-ros oncogene 1 (ROS1) receptor tyrosine kinase via molecular dynamics simulation and binding free energy calculations.
    Wu X; Wang Y; Wan S; Zhang J
    J Biomol Struct Dyn; 2018 Sep; 36(12):3106-3113. PubMed ID: 28893136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of acetylcholinesterase by two genistein derivatives: kinetic analysis, molecular docking and molecular dynamics simulation.
    Fang J; Wu P; Yang R; Gao L; Li C; Wang D; Wu S; Liu AL; Du GH
    Acta Pharm Sin B; 2014 Dec; 4(6):430-7. PubMed ID: 26579414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHARMM-GUI Free Energy Calculator for Absolute and Relative Ligand Solvation and Binding Free Energy Simulations.
    Kim S; Oshima H; Zhang H; Kern NR; Re S; Lee J; Roux B; Sugita Y; Jiang W; Im W
    J Chem Theory Comput; 2020 Nov; 16(11):7207-7218. PubMed ID: 33112150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advancing Drug Discovery through Enhanced Free Energy Calculations.
    Abel R; Wang L; Harder ED; Berne BJ; Friesner RA
    Acc Chem Res; 2017 Jul; 50(7):1625-1632. PubMed ID: 28677954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative Binding Free Energy Calculations Applied to Protein Homology Models.
    Cappel D; Hall ML; Lenselink EB; Beuming T; Qi J; Bradner J; Sherman W
    J Chem Inf Model; 2016 Dec; 56(12):2388-2400. PubMed ID: 28024402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the performance of docking, FEP, and MM/GBSA methods on a series of KLK6 inhibitors.
    Lima Silva WJ; Ferreira de Freitas R
    J Comput Aided Mol Des; 2023 Sep; 37(9):407-418. PubMed ID: 37378817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of an automated procedure for the prediction of relative free energies of binding on a set of aldose reductase inhibitors.
    Ferrari AM; Degliesposti G; Sgobba M; Rastelli G
    Bioorg Med Chem; 2007 Dec; 15(24):7865-77. PubMed ID: 17870536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular dynamics simulation and binding free energy studies of novel leads belonging to the benzofuran class inhibitors of Mycobacterium tuberculosis Polyketide Synthase 13.
    Cruz JN; Costa JFS; Khayat AS; Kuca K; Barros CAL; Neto AMJC
    J Biomol Struct Dyn; 2019 Apr; 37(6):1616-1627. PubMed ID: 29633908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the performance of MM/PBSA and MM/GBSA methods. 7. Entropy effects on the performance of end-point binding free energy calculation approaches.
    Sun H; Duan L; Chen F; Liu H; Wang Z; Pan P; Zhu F; Zhang JZH; Hou T
    Phys Chem Chem Phys; 2018 May; 20(21):14450-14460. PubMed ID: 29785435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular basis for the selectivity of tadalafil toward phosphodiesterase 5 and 6: a modeling study.
    Huang YY; Li Z; Cai YH; Feng LJ; Wu Y; Li X; Luo HB
    J Chem Inf Model; 2013 Nov; 53(11):3044-53. PubMed ID: 24180640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling Local Structural Rearrangements Using FEP/REST: Application to Relative Binding Affinity Predictions of CDK2 Inhibitors.
    Wang L; Deng Y; Knight JL; Wu Y; Kim B; Sherman W; Shelley JC; Lin T; Abel R
    J Chem Theory Comput; 2013 Feb; 9(2):1282-93. PubMed ID: 26588769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerating and Automating the Free Energy Perturbation Absolute Binding Free Energy Calculation with the RED-E Function.
    Liu R; Li W; Yao Y; Wu Y; Luo HB; Li Z
    J Chem Inf Model; 2023 Dec; 63(24):7755-7767. PubMed ID: 38048439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Free energy perturbation-based large-scale virtual screening for effective drug discovery against COVID-19.
    Li Z; Wu C; Li Y; Liu R; Lu K; Wang R; Liu J; Gong C; Yang C; Wang X; Zhan CG; Luo HB
    Int J High Perform Comput Appl; 2023 Jan; 37(1):45-57. PubMed ID: 38603271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QligFEP: an automated workflow for small molecule free energy calculations in Q.
    Jespers W; Esguerra M; Åqvist J; Gutiérrez-de-Terán H
    J Cheminform; 2019 Apr; 11(1):26. PubMed ID: 30941533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calculation of relative binding free energy differences for fructose 1,6-bisphosphatase inhibitors using the thermodynamic cycle perturbation approach.
    Reddy MR; Erion MD
    J Am Chem Soc; 2001 Jul; 123(26):6246-52. PubMed ID: 11427047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Advances in Scaffold Hopping.
    Hu Y; Stumpfe D; Bajorath J
    J Med Chem; 2017 Feb; 60(4):1238-1246. PubMed ID: 28001064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accurate calculation of absolute free energy of binding for SHP2 allosteric inhibitors using free energy perturbation.
    Liang L; Liu H; Xing G; Deng C; Hua Y; Gu R; Lu T; Chen Y; Zhang Y
    Phys Chem Chem Phys; 2022 May; 24(17):9904-9920. PubMed ID: 35416820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.